<DOC>
	<DOCNO>NCT00446979</DOCNO>
	<brief_summary>This study help determine whether UC-781 gel safe apply vagina twice daily 14 day , assess whether woman men find gel acceptable use .</brief_summary>
	<brief_title>Safety Study UC-781 Vaginal Microbicide</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Inclusion Criteria woman : Age 1850 year old Regular menses HIV1 seronegative screening Normal Pap smear screen document normal Pap smear within six month prior screen No evidence reproductive tract infection ( RTI ) Willing able comply study procedure , include pelvic exam , colposcopy , maintain study coital symptom log , apply assign study gel per protocol Agree abstain sexual intercourse 24 hour prior enrollment visit Agree abstain follow activity least 48 hour prior enrollment Day 14 visit : Insertion finger object vagina Receiving oral sex Receiving anal sex Using diaphragm , cervical cap , female condom , vaginal contraceptive ring Using vaginal product study gel , include douche , lubricant , feminine hygiene product In monogamous sexually active relationship one male partner Report vaginal intercourse partner least two time per week No report partner prior six month plan another partner duration study Agree use condom act vaginal intercourse participation study Their male partner inform also consent participate study Willing male partner inform treat STD diagnose screen study Inclusion Criteria men : Age 18 year older HIVseronegative free STI screen exam One female sexual partner ; report partner prior six month plan another partner duration study Willing able comply study procedure , include clinic visit , interview acceptability evaluation , consistent use condom enrollment study Willing female partner inform treat STD diagnose screen study Exclusion Criteria woman : Pregnancy desire become pregnant time study participation Currently breastfeed Delivery abortion within last eight week History male sexual partner current partner past six month No abnormal ( DAIDS grade 1 high ) laboratory result baseline , include hematology , liver kidney function History postcoital vaginal bleeding past three month History surgery remove uterus cervix History surgery external genitalia , vaginal , cervix past month Clinically significant chronic medical condition consider progressive , include cardiopulmonary disease , renal disease , hepatic disease , diabetes mellitus . History sensitivity/allergy latex Existence clinically detectable genital abnormality screening ( e.g . ulcer , congenital abnormality , lesion mucosal disruption ) Concurrent participation another trial vaginal product Have condition opinion investigator might interfere evaluation study objective Exclusion Criteria men : History genital surgery past month Clinical laboratory evidence STI . History sensitivity/allergy latex History sexual partner current partner past six month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Microbicides</keyword>
	<keyword>HIV seronegativity</keyword>
</DOC>